{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:10:50Z","timestamp":1771485050806,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Fungal Infect Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12281-019-00345-7","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T07:02:41Z","timestamp":1563778961000},"page":"99-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical Aspects of Immune Damage in Cryptococcosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Seher","family":"Anjum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"issue":"3","key":"345_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/qjmed\/hcl014","volume":"99","author":"G Lui","year":"2006","unstructured":"Lui G, et al. Cryptococcosis in apparently immunocompetent patients. QJM. 2006;99(3):143\u201351. \n                      https:\/\/doi.org\/10.1093\/qjmed\/hcl014\n                      \n                    .","journal-title":"QJM"},{"issue":"3","key":"345_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJM197907193010303","volume":"301","author":"JE Bennett","year":"1979","unstructured":"Bennett JE, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 1979;301(3):126\u201331. \n                      https:\/\/doi.org\/10.1056\/NEJM197907193010303\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"6","key":"345_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1086\/368091","volume":"36","author":"SA Mirza","year":"2003","unstructured":"Mirza SA, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000. Clin Infect Dis. 2003;36(6):789\u201394. \n                      https:\/\/doi.org\/10.1086\/368091\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"8","key":"345_CR4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873\u201381. \n                      https:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8\n                      \n                    .","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"345_CR5","doi-asserted-by":"publisher","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","volume":"4","author":"KJ Kwon-Chung","year":"2014","unstructured":"Kwon-Chung KJ, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014;4(7):a019760. \n                      https:\/\/doi.org\/10.1101\/cshperspect.a019760\n                      \n                    .","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"345_CR6","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1128\/AAC.02287-12","volume":"57","author":"CE Gast","year":"2013","unstructured":"Gast CE, et al. Azole resistance in Cryptococcus gattii from the Pacific Northwest: investigation of the role of ERG11. Antimicrob Agents Chemother. 2013;57(11):5478\u201385. \n                      https:\/\/doi.org\/10.1128\/AAC.02287-12\n                      \n                    .","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"345_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","volume":"13","author":"PR Williamson","year":"2017","unstructured":"\u2022 Williamson PR, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2017;13(1):13\u201324. \n                      https:\/\/doi.org\/10.1038\/nrneurol.2016.167\n                      \n                    \n                              An updated review of the epidemiology, immune pathology, and clinical management strategies for HIV-associated and HIV-seronegative cryptococcal meningitis patients.","journal-title":"Nat Rev Neurol"},{"key":"345_CR8","doi-asserted-by":"publisher","unstructured":"Hagen F, et al. Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus genus. mSphere. 2017;2(4). \n                      https:\/\/doi.org\/10.1128\/mSphere.00238-17\n                      \n                    .","DOI":"10.1128\/mSphere.00238-17"},{"key":"345_CR9","doi-asserted-by":"publisher","unstructured":"Kwon-Chung KJ, et al. The case for adopting the \u201cSpecies Complex\u201d nomenclature for the etiologic agents of cryptococcosis. mSphere. 2017;2(1). \n                      https:\/\/doi.org\/10.1128\/mSphere.00357-16\n                      \n                    .","DOI":"10.1128\/mSphere.00357-16"},{"issue":"2","key":"345_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1086\/313992","volume":"31","author":"S Chen","year":"2000","unstructured":"Chen S, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31(2):499\u2013508. \n                      https:\/\/doi.org\/10.1086\/313992\n                      \n                    .","journal-title":"Clin Infect Dis"},{"key":"345_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fmicb.2019.00353","volume":"10","author":"K Vu","year":"2019","unstructured":"Vu K, Garcia JA, Gelli A. Cryptococcal meningitis and anti-virulence therapeutic strategies. Front Microbiol. 2019;10:353. \n                      https:\/\/doi.org\/10.3389\/fmicb.2019.00353\n                      \n                    .","journal-title":"Front Microbiol"},{"key":"345_CR12","doi-asserted-by":"publisher","unstructured":"Waterman SR, et al. Role of CTR4 in the virulence of Cryptococcus neoformans. MBio. 2012;3(5). \n                      https:\/\/doi.org\/10.1128\/mBio.00285-12e00285-12\n                      \n                    .","DOI":"10.1128\/mBio.00285-12e00285-12"},{"key":"345_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12281-011-0069-3","volume":"5","author":"S Chen","year":"2011","unstructured":"Chen S, Williamson P. Lessons from cryptococcal laccase: from environmental saprophyte to pathogen. Curr Fungal Infect Rep. 2011;5:233\u201344.","journal-title":"Curr Fungal Infect Rep"},{"issue":"7","key":"345_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/myc.12619","volume":"60","author":"MC Olave","year":"2017","unstructured":"Olave MC, et al. Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line. Mycoses. 2017;60(7):447\u201353. \n                      https:\/\/doi.org\/10.1111\/myc.12619\n                      \n                    .","journal-title":"Mycoses"},{"issue":"10","key":"345_CR15","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1128\/JCM.37.10.3204-3209.1999","volume":"37","author":"D Garcia-Hermoso","year":"1999","unstructured":"Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol. 1999;37(10):3204\u20139.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"345_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.meegid.2009.01.013","volume":"9","author":"X Lin","year":"2009","unstructured":"Lin X. Cryptococcus neoformans: morphogenesis, infection, and evolution. Infect Genet Evol. 2009;9(4):401\u201316. \n                      https:\/\/doi.org\/10.1016\/j.meegid.2009.01.013\n                      \n                    .","journal-title":"Infect Genet Evol"},{"issue":"12","key":"345_CR17","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1128\/CVI.00242-07","volume":"14","author":"DC Saha","year":"2007","unstructured":"Saha DC, et al. Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients. Clin Vaccine Immunol. 2007;14(12):1550\u20134. \n                      https:\/\/doi.org\/10.1128\/CVI.00242-07\n                      \n                    .","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"345_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/IAI.01065-08","volume":"77","author":"C Charlier","year":"2009","unstructured":"Charlier C, et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun. 2009;77(1):120\u20137. \n                      https:\/\/doi.org\/10.1128\/IAI.01065-08\n                      \n                    .","journal-title":"Infect Immun"},{"issue":"1","key":"345_CR19","doi-asserted-by":"publisher","first-page":"e29561","DOI":"10.1371\/journal.pone.0029561","volume":"7","author":"S Araujo Gde","year":"2012","unstructured":"Araujo Gde S, et al. Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells. PLoS One. 2012;7(1):e29561. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0029561\n                      \n                    .","journal-title":"PLoS One"},{"issue":"5","key":"345_CR20","doi-asserted-by":"publisher","first-page":"e1004037","DOI":"10.1371\/journal.ppat.1004037","volume":"10","author":"Y-D Park","year":"2014","unstructured":"Park Y-D, et al. A role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans Capsule. PLoS Pathog. 2014;10(5):e1004037. \n                      https:\/\/doi.org\/10.1371\/journal.ppat.1004037\n                      \n                    .","journal-title":"PLoS Pathog"},{"key":"345_CR21","doi-asserted-by":"publisher","unstructured":"He X, et al. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination. Am J Pathol. 2012;S0002\u20139440(12):00487\u20137. \n                      https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.012\n                      \n                    .","DOI":"10.1016\/j.ajpath.2012.06.012"},{"key":"345_CR22","doi-asserted-by":"crossref","unstructured":"Panepinto J, et al. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. 2008.","DOI":"10.1111\/j.1365-2958.2008.06588.x"},{"issue":"12","key":"345_CR23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/EC.00103-15","volume":"14","author":"F Almeida","year":"2015","unstructured":"\u2022 Almeida F, Wolf JM, Casadevall A. Virulence-associated enzymes of Cryptococcus neoformans. Eukaryot Cell. 2015;14(12):1173\u201385. \n                      https:\/\/doi.org\/10.1128\/EC.00103-15\n                      \n                    \n                              A review of newly discovered enzymatic mechanisms through which\n                              Cryptococcus neoformans\n                              adapts to survive and infect mammalian hosts.","journal-title":"Eukaryot Cell"},{"issue":"2","key":"345_CR24","doi-asserted-by":"publisher","first-page":"ofx082","DOI":"10.1093\/ofid\/ofx082","volume":"4","author":"AA Panackal","year":"2017","unstructured":"\u2022 Panackal AA, et al. Susceptibility to cryptococcal meningoencephalitis associated with idiopathic CD4(+) lymphopenia and secondary germline or acquired defects. Open Forum Infect Dis. 2017;4(2):ofx082. \n                      https:\/\/doi.org\/10.1093\/ofid\/ofx082\n                      \n                    \n                              Two case studies of patients with idiopathic CD4+ lymphopenia (ICL) and opportunistic cryptococcal meningoencephalitis infections with an immunological focus on the E57K genetic mutation and acquired granulocyte-macrophage colony-stimulating factor autoantibodies.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"345_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/md.0b013e31803b52f5","volume":"86","author":"DI Zonios","year":"2007","unstructured":"Zonios DI, et al. Cryptococcosis and idiopathic CD4 lymphocytopenia. Medicine (Baltimore). 2007;86(2):78\u201392. \n                      https:\/\/doi.org\/10.1097\/md.0b013e31803b52f5\n                      \n                    .","journal-title":"Medicine (Baltimore)"},{"key":"345_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fimmu.2018.00651","volume":"9","author":"W Elsegeiny","year":"2018","unstructured":"\u2022\u2022 Elsegeiny W, Marr KA, Williamson PR. Immunology of cryptococcal infections: developing a rational approach to patient therapy. Front Immunol. 2018;9:651. \n                      https:\/\/doi.org\/10.3389\/fimmu.2018.00651\n                      \n                    \n                              New insights on immune activation in HIV-positive and previously healthy patients with cryptococcal meningoencephalitis to update treatment strategies.","journal-title":"Front Immunol"},{"issue":"3","key":"345_CR27","doi-asserted-by":"publisher","first-page":"e60431","DOI":"10.1371\/journal.pone.0060431","volume":"8","author":"KD Brizendine","year":"2013","unstructured":"\u2022\u2022 Brizendine KD, Baddley JW, Pappas PG. Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. PLoS One. 2013;8(3):e60431. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0060431\n                      \n                    \n                              A retrospective cohort study of 302 patients with cryptococcosis that identifies cryptococcemia, high intracranial pressure, and a non-HIV, non-transplant immune status as predictive markers for mortality.","journal-title":"PLoS One"},{"issue":"5","key":"345_CR28","doi-asserted-by":"publisher","first-page":"e1004884","DOI":"10.1371\/journal.ppat.1004884","volume":"11","author":"AA Panackal","year":"2015","unstructured":"\u2022\u2022 Panackal AA, et al. Paradoxical immune responses in non-HIV cryptococcal meningitis. PLoS Pathog. 2015;11(5):e1004884. \n                      https:\/\/doi.org\/10.1371\/journal.ppat.1004884\n                      \n                    \n                              This immunological study higlights unusual findings of strong intrathecal expansion and activation of T cells involved in both innate and adaptive immunity in HIV-negative patients with cryptococcal meningoencephalitis.","journal-title":"PLoS Pathog"},{"key":"345_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-0-387-09550-9_11","volume":"635","author":"LA Pirofski","year":"2008","unstructured":"\u2022\u2022 Pirofski LA, Casadevall A. The damage-response framework of microbial pathogenesis and infectious diseases. Adv Exp Med Biol. 2008;635:135\u201346. \n                      https:\/\/doi.org\/10.1007\/978-0-387-09550-9_11\n                      \n                    \n                              An overview of the damage-response framework explains how an imbalance in the host-microbe interaction can determine variable outcomes in different patients.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"345_CR30","first-page":"67","volume":"5","author":"SA Shelburne 3rd","year":"2003","unstructured":"Shelburne SA 3rd, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev. 2003;5(2):67\u201379.","journal-title":"AIDS Rev"},{"issue":"6","key":"345_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/infdis\/jiy602","volume":"219","author":"L Tugume","year":"2019","unstructured":"Tugume L, et al. HIV-associated cryptococcal meningitis occurring at relatively higher CD4 counts. J Infect Dis. 2019;219(6):877\u201383. \n                      https:\/\/doi.org\/10.1093\/infdis\/jiy602\n                      \n                    .","journal-title":"J Infect Dis"},{"issue":"3","key":"345_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1399-3062.2010.00592.x","volume":"13","author":"T Legris","year":"2011","unstructured":"Legris T, et al. Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient. Transpl Infect Dis. 2011;13(3):303\u20138. \n                      https:\/\/doi.org\/10.1111\/j.1399-3062.2010.00592.x\n                      \n                    .","journal-title":"Transpl Infect Dis"},{"key":"345_CR33","doi-asserted-by":"publisher","unstructured":"Neal LM, et al. CD4(+) T cells orchestrate lethal immune pathology despite fungal clearance during Cryptococcus neoformans meningoencephalitis. MBio. 2017;8(6). \n                      https:\/\/doi.org\/10.1128\/mBio.01415-17\n                      \n                    .","DOI":"10.1128\/mBio.01415-17"},{"key":"345_CR34","doi-asserted-by":"publisher","unstructured":"\u2022 Panackal AA, et al. Fighting the monster: applying the host damage framework to human central nervous system infections. MBio. 2016;7(1). \n                      https:\/\/doi.org\/10.1128\/mBio.01906-15\n                      \n                    \n                              This review applies the host damage-response framework to nonviral generalized CNS infections, including cryptococcal meningitis in non-HIV-infected patients.","DOI":"10.1128\/mBio.01906-15"},{"issue":"1","key":"345_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hiv.12676","volume":"20","author":"A Balasko","year":"2019","unstructured":"\u2022\u2022 Balasko A, Keynan Y. Shedding light on IRIS: from pathophysiology to treatment of cryptococcal meningitis and immune reconstitution inflammatory syndrome in HIV-infected individuals. HIV Med. 2019;20(1):1\u201310. \n                      https:\/\/doi.org\/10.1111\/hiv.12676\n                      \n                    \n                              A review of the pathophysiology of HIV-associated cryptococcal immune reconstitution inflammatory syndrome with the consideration of thalidomide as a targeted alternative for type 1 T helper (Th1) cell overcompensation.","journal-title":"HIV Med"},{"issue":"4","key":"345_CR36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jmii.2011.12.005","volume":"45","author":"CH Liao","year":"2012","unstructured":"\u2022 Liao CH, et al. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with cryptococcal meningitis. J Microbiol Immunol Infect. 2012;45(4):296\u2013304. \n                      https:\/\/doi.org\/10.1016\/j.jmii.2011.12.005\n                      \n                    \n                              A retrospective study describing potential predictors of outcomes with findings of lower mortality rates in HIV-infected CM compared with non-HIV patients with CM.","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"345_CR37","doi-asserted-by":"publisher","first-page":"e43582","DOI":"10.1371\/journal.pone.0043582","volume":"7","author":"EW Bratton","year":"2012","unstructured":"\u2022 Bratton EW, et al. Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative\/non-transplant. PLoS One. 2012;7(8):e43582. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0043582\n                      \n                    \n                              This study compares trends for cryptococcosis in patients with varying immune status with the main finding of an increased prevalence in HIV-uninfected cases.","journal-title":"PLoS One"},{"issue":"5","key":"345_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jinf.2010.08.004","volume":"61","author":"MH Nguyen","year":"2010","unstructured":"\u2022 Nguyen MH, et al. Outcomes of central nervous system cryptococcosis vary with host immune function: results from a multi-center, prospective study. J Infect. 2010;61(5):419\u201326. \n                      https:\/\/doi.org\/10.1016\/j.jinf.2010.08.004\n                      \n                    \n                              This observational study demonstrated significant differences in outcomes for CNS cryptococcosis in relation to host immune status with the main finding of a higher mortality rate in non-immunocompromised patients.","journal-title":"J Infect"},{"key":"345_CR39","first-page":"61","volume":"124","author":"PG Pappas","year":"2013","unstructured":"Pappas PG. Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc. 2013;124:61\u201379.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"345_CR40","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Marr KA, et al. A multicenter, longitudinal cohort study of cryptococcosis in HIV-negative people in the United States. Clin Infect Dis. 2019. \n                      https:\/\/doi.org\/10.1093\/cid\/ciz193\n                      \n                    \n                              This prospective cohort study identified declining Montreal Cognitive Assessment (MoCA) scores and subsequent long-term neurological sequelae in HIV-uninfected patients despite the use of antifungal therapy.","DOI":"10.1093\/cid\/ciz193"},{"issue":"Suppl 1","key":"345_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/ofid\/ofw194.35","volume":"3","author":"A Spec","year":"2016","unstructured":"Spec A, et al. Cryptococcus Infection Network in Non-Human Immunodeficiency Virus Cohort (CINCH) study: initial report of treatment and outcomes. Open Forum Infect Dis. 2016;3(Suppl 1):122. \n                      https:\/\/doi.org\/10.1093\/ofid\/ofw194.35\n                      \n                    .","journal-title":"Open Forum Infect Dis"},{"key":"345_CR42","doi-asserted-by":"crossref","unstructured":"Traino K. HIV-negative cryptococcal meningoencephalitis results in a persistent frontal-subcortical syndrome. Nat Sci Rep. 2019; (in press).","DOI":"10.1038\/s41598-019-54876-7"},{"key":"345_CR43","doi-asserted-by":"crossref","unstructured":"King KA, GA AAP, Zalewski C, Anjum S, Bennett JE, Beri A, et al. Audiologic and otologic complications of cryptococcal meningoencephalitis in non-HIV previously healthy patients. Otol Neurotol. 2019; (in press).","DOI":"10.1097\/MAO.0000000000002242"},{"issue":"3","key":"345_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/cid\/ciw739","volume":"64","author":"AA Panackal","year":"2017","unstructured":"Panackal AA, et al. Spinal arachnoiditis as a complication of cryptococcal meningoencephalitis in non-HIV previously healthy adults. Clin Infect Dis. 2017;64(3):275\u201383. \n                      https:\/\/doi.org\/10.1093\/cid\/ciw739\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"2","key":"345_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s40588-017-0064-8","volume":"4","author":"JA O'Halloran","year":"2017","unstructured":"O'Halloran JA, Powderly WG, Spec A. Cryptococcosis today: it is not all about HIV infection. Curr Clin Microbiol Rep. 2017;4(2):88\u201395. \n                      https:\/\/doi.org\/10.1007\/s40588-017-0064-8\n                      \n                    .","journal-title":"Curr Clin Microbiol Rep"},{"issue":"7","key":"345_CR46","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/cid\/cix870","volume":"66","author":"E Pasquier","year":"2018","unstructured":"Pasquier E, et al. Long-term mortality and fisability in cryptococcal meningitis: a systematic literature review. Clin Infect Dis. 2018;66(7):1122\u201332. \n                      https:\/\/doi.org\/10.1093\/cid\/cix870\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"3","key":"345_CR47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/MAJ.0000000000000217","volume":"348","author":"E Chow","year":"2014","unstructured":"Chow E, Troy SB. The differential diagnosis of hypoglycorrhachia in adult patients. Am J Med Sci. 2014;348(3):186\u201390. \n                      https:\/\/doi.org\/10.1097\/MAJ.0000000000000217\n                      \n                    .","journal-title":"Am J Med Sci"},{"issue":"1","key":"345_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.24408","volume":"78","author":"M Komori","year":"2015","unstructured":"Komori M, et al. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis. Ann Neurol. 2015;78(1):3\u201320. \n                      https:\/\/doi.org\/10.1002\/ana.24408\n                      \n                    .","journal-title":"Ann Neurol"},{"issue":"2","key":"345_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12281-016-0256-3","volume":"10","author":"E Nalintya","year":"2016","unstructured":"Nalintya E, Kiggundu R, Meya D. Evolution of cryptococcal antigen testing: what is new? Curr Fungal Infect Rep. 2016;10(2):62\u20137. \n                      https:\/\/doi.org\/10.1007\/s12281-016-0256-3\n                      \n                    .","journal-title":"Curr Fungal Infect Rep"},{"issue":"2","key":"345_CR50","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/JCM.02223-15","volume":"54","author":"A Jitmuang","year":"2016","unstructured":"Jitmuang A, et al. Performance of the cryptococcal antigen lateral flow assay in non-HIV-related cryptococcosis. J Clin Microbiol. 2016;54(2):460\u20133. \n                      https:\/\/doi.org\/10.1128\/JCM.02223-15\n                      \n                    .","journal-title":"J Clin Microbiol"},{"key":"345_CR51","doi-asserted-by":"publisher","unstructured":"Liesman RM, et al. Evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis. J Clin Microbiol. 2018;56(4). \n                      https:\/\/doi.org\/10.1128\/JCM.01927-17\n                      \n                    .","DOI":"10.1128\/JCM.01927-17"},{"issue":"5","key":"345_CR52","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1086\/317434","volume":"31","author":"DR Hospenthal","year":"2000","unstructured":"Hospenthal DR, Bennett JE. Persistence of cryptococcomas on neuroimaging. Clin Infect Dis. 2000;31(5):1303\u20136. \n                      https:\/\/doi.org\/10.1086\/317434\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"1","key":"345_CR53","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12879-018-3386-0","volume":"18","author":"JP Ellis","year":"2018","unstructured":"Ellis JP, et al. Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report. BMC Infect Dis. 2018;18(1):520. \n                      https:\/\/doi.org\/10.1186\/s12879-018-3386-0\n                      \n                    .","journal-title":"BMC Infect Dis"},{"issue":"1","key":"345_CR54","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1038\/s41598-017-09694-0","volume":"7","author":"DA Hammoud","year":"2017","unstructured":"Hammoud DA, et al. Choroid plexitis and ependymitis by magnetic resonance imaging are biomarkers of neuronal damage and inflammation in HIV-negative cryptococcal meningoencephalitis. Sci Rep. 2017;7(1):9184. \n                      https:\/\/doi.org\/10.1038\/s41598-017-09694-0\n                      \n                    .","journal-title":"Sci Rep"},{"issue":"Suppl","key":"345_CR55","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.parint.2005.11.016","volume":"55","author":"OM Takayanagui","year":"2006","unstructured":"Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis. Parasitol Int. 2006;55(Suppl):S111\u20135. \n                      https:\/\/doi.org\/10.1016\/j.parint.2005.11.016\n                      \n                    .","journal-title":"Parasitol Int"},{"issue":"1","key":"345_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","volume":"50","author":"P Schwarz","year":"2006","unstructured":"Schwarz P, et al. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother. 2006;50(1):113\u201320. \n                      https:\/\/doi.org\/10.1128\/AAC.50.1.113-120.2006\n                      \n                    .","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"345_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","volume":"80","author":"RD Diamond","year":"1974","unstructured":"Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann Intern Med. 1974;80(2):176\u201381.","journal-title":"Ann Intern Med"},{"issue":"3","key":"345_CR58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"\u2022 Perfect JR, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291\u2013322. \n                      https:\/\/doi.org\/10.1086\/649858\n                      \n                    \n                              IDSA clinical practice guidelines for cryptococcosis in HIV-infected individuals, organ transplant recipients, and non-HIV-infected (non-transplant) patients.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"345_CR59","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMoa1509024","volume":"374","author":"J Beardsley","year":"2016","unstructured":"\u2022 Beardsley J, et al. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis. N Engl J Med. 2016;374(6):542\u201354. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1509024\n                      \n                    \n                              This is a double-blind, randomized, placebo-controlled landmark trial of dexamethasone use in HIV-infected patients with cryptococcal meningitis that demonstrated no improvement in outcomes for the experimental group.","journal-title":"N Engl J Med"},{"issue":"1","key":"345_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12883-018-1053-0","volume":"18","author":"J Liu","year":"2018","unstructured":"Liu J, et al. Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis. BMC Neurol. 2018;18(1):58. \n                      https:\/\/doi.org\/10.1186\/s12883-018-1053-0\n                      \n                    .","journal-title":"BMC Neurol"},{"issue":"12","key":"345_CR61","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.4067\/s0034-98872018001201481","volume":"146","author":"RM Tellez","year":"2018","unstructured":"Tellez RM, et al. Cerebral cryptococcosis and immune reconstitution inflammatory syndrome. Case report. Rev Med Chil. 2018;146(12):1481\u20135. \n                      https:\/\/doi.org\/10.4067\/s0034-98872018001201481\n                      \n                    .","journal-title":"Rev Med Chil"},{"issue":"2","key":"345_CR62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/jnnp-2017-315830","volume":"89","author":"GU Mehta","year":"2018","unstructured":"\u2022 Mehta GU, et al. Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis. J Neurol Neurosurg Psychiatry. 2018;89(2):219\u201320. \n                      https:\/\/doi.org\/10.1136\/jnnp-2017-315830\n                      \n                    \n                              This letter details the successful use of corticosteroids as well as antifungal therapy to control post-infectious inflammatory response syndrome (PIIRS) and prevent long-term neurological complications in cryptococcal meningitis (CM) patients.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"345_CR63","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1212\/01.WNL.0000134677.29120.62","volume":"63","author":"M Lane","year":"2004","unstructured":"Lane M, McBride J, Archer J. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis. Neurology. 2004;63(4):713\u20134.","journal-title":"Neurology"},{"issue":"4","key":"345_CR64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/cid\/cit341","volume":"57","author":"SC Chen","year":"2013","unstructured":"Chen SC, et al. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis. 2013;57(4):543\u201351. \n                      https:\/\/doi.org\/10.1093\/cid\/cit341\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"1","key":"345_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/oxfordjournals.aje.a113861","volume":"120","author":"KJ Kwon-Chung","year":"1984","unstructured":"Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984;120(1):123\u201330.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"345_CR66","doi-asserted-by":"publisher","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","volume":"8","author":"V Pyrgos","year":"2013","unstructured":"Pyrgos V, et al. Epidemiology of cryptococcal meningitis in the US: 1997\u20132009. PLoS One. 2013;8(2):e56269. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0056269\n                      \n                    .","journal-title":"PLoS One"},{"issue":"3","key":"345_CR67","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/QAD.0b013e328333c005","volume":"24","author":"A Loyse","year":"2010","unstructured":"Loyse A, et al. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure. AIDS. 2010;24(3):405\u201310. \n                      https:\/\/doi.org\/10.1097\/QAD.0b013e328333c005\n                      \n                    .","journal-title":"AIDS"},{"issue":"1","key":"345_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1086\/313603","volume":"30","author":"JR Graybill","year":"2000","unstructured":"Graybill JR, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000;30(1):47\u201354. \n                      https:\/\/doi.org\/10.1086\/313603\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"3","key":"345_CR69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1086\/515161","volume":"28","author":"MK Park","year":"1999","unstructured":"Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis. 1999;28(3):629\u201333. \n                      https:\/\/doi.org\/10.1086\/515161\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"3","key":"345_CR70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/MCP.0b013e328344f692","volume":"17","author":"G Calligaro","year":"2011","unstructured":"Calligaro G, Meintjes G, Mendelson M. Pulmonary manifestations of the immune reconstitution inflammatory syndrome. Curr Opin Pulm Med. 2011;17(3):180\u20138. \n                      https:\/\/doi.org\/10.1097\/MCP.0b013e328344f692\n                      \n                    .","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"345_CR71","doi-asserted-by":"publisher","first-page":"e0173858","DOI":"10.1371\/journal.pone.0173858","volume":"12","author":"Z Hu","year":"2017","unstructured":"Hu Z, et al. Radiological characteristics of pulmonary cryptococcosis in HIV-infected patients. PLoS One. 2017;12(3):e0173858. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0173858\n                      \n                    .","journal-title":"PLoS One"},{"issue":"12","key":"345_CR72","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1086\/344467","volume":"35","author":"ER Jenny-Avital","year":"2002","unstructured":"Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis. 2002;35(12):e128\u201333. \n                      https:\/\/doi.org\/10.1086\/344467\n                      \n                    .","journal-title":"Clin Infect Dis"},{"issue":"4","key":"345_CR73","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1128\/CVI.00732-12","volume":"20","author":"MA Gates-Hollingsworth","year":"2013","unstructured":"Gates-Hollingsworth MA, Kozel TR. Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen. Clin Vaccine Immunol. 2013;20(4):634\u20135. \n                      https:\/\/doi.org\/10.1128\/CVI.00732-12\n                      \n                    .","journal-title":"Clin Vaccine Immunol"}],"container-title":["Current Fungal Infection Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12281-019-00345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12281-019-00345-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12281-019-00345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T23:15:13Z","timestamp":1595286913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12281-019-00345-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1007\/s12281-019-00345-7","relation":{},"ISSN":["1936-3761","1936-377X"],"issn-type":[{"value":"1936-3761","type":"print"},{"value":"1936-377X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"22 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}